There are a variety of drugs and isotopes that are offered at Mobile Molecular Imaging in an effort to properly diagnose cancer. The type of drug or isotope that is used will depend on what your physician is looking for or wanting to measure. A positive emission tomography (PET) scan is a nuclear imaging test that works with computed tomography (CT) and a radioactive tracer in an effort to see what your body tissues will absorb. In some cases, a computed tomography (CT) can be done at the same time and can merge the images together. This full body scan is able to capture neuroendocrine tumors (NETs). Before the scan is performed, the tracer is injected directly into the bloodstream. Once it has been absorbed, the scan is performed.

F18 FDG or Fludeoxyglucose injection is used to aid in diagnosing cancer and is a radiopharmaceutical. Right before your scan, this drug will be inserted into one of your veins. This is most commonly used to view parts of the body, such as the heart and the brain.

Axumin (fluciclovine F 18) injections are used in PET scans in men that are suspected to have prostate cancer. This could be suspected because of elevated prostate specific antigen (PSA) or recurring cancer.

Gallium 68 or Netspot is a radiopharmaceutical tracer that is used during positive emission tomography (PET) scans. This medicine will be given to you through a needle that is placed in one of your veins just before your scan. This type of scan is used to identify which cells are dividing the most quickly in the body. It is most common in people with lymphoma, bone cancer, or lung cancer. The scan is able to show how the cancer has spread and/ or if the treatment is effective.

Cerianna (Fluoroestradioal F 18) Injection is a radioactive diagnostic agent that is used in PET scans. This type of drug is used in detecting estrogen receptor (ER) – positive lesions, which is for patients with recurrent or metastatic breast cancer.